PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $174,000 | +54.0% | 18,979 | +62.8% | 0.02% | +30.8% |
| Q1 2021 | $113,000 | -21.0% | 11,657 | -17.5% | 0.01% | -43.5% |
| Q3 2020 | $143,000 | -49.8% | 14,124 | -58.1% | 0.02% | -58.9% |
| Q1 2020 | $285,000 | +9.2% | 33,731 | +13.0% | 0.06% | +33.3% |
| Q4 2019 | $261,000 | +4.4% | 29,844 | +28.5% | 0.04% | -4.5% |
| Q3 2019 | $250,000 | -27.7% | 23,217 | +160.3% | 0.04% | -22.8% |
| Q1 2019 | $346,000 | +10.2% | 8,921 | -42.2% | 0.06% | +5.6% |
| Q4 2018 | $314,000 | +33.6% | 15,430 | +340.9% | 0.05% | -14.3% |
| Q3 2016 | $235,000 | – | 3,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |